Oxford University vaccine results show strong immune response in older demographic
Oxford University vaccine results show strong immune response in older demographic

Oxford University this morning announced more promising news in the development of its COVID-19 vaccine.

The results from Phase 2 of its AZD122 vaccine trial, published in the Lancet on Thursday, show that the vaccine is as effective for the older demographic as it is for the younger.

Story: https://wfts.tv/3pM5mAe